查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1370921

體外毒理學測試市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按技術、按應用、方法、最終用戶、地區、競爭細分

In-vitro Toxicology Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Technology, By Application, By Method, By End-User, By Region, Competition
出版日期: | 出版商: TechSci Research | 英文 183 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2022年，全球體外毒理學測試市場估值達到160.9億美元，預計將呈現強勁成長，年複合成長率（CAGR）為9.66%，預計到2028年將達到278.8億美元。測試涉及評估各種物質對生物體以外的生物系統的潛在毒性影響的科學過程。這些評估通常在受控實驗室環境中使用試管、培養皿或人工系統進行，從而複製了拉丁術語“體外”，意思是“在玻璃中”。這種方法提供了對細胞、分子和生化層面的毒理學影響的深入了解，可作為評估化學物質、藥物、化妝品和消費品安全性的寶貴工具，且不會傷害動物或人類。

主要市場促進因素

對新藥和化學品安全評估的需求不斷增加

市場概況
預測期 2024-2028
2022 年市場規模 160.9億美元
2028 年市場規模 278.8億美元
2023-2028 年年複合成長率 9.66%
成長最快的細分市場 細胞培養技術
最大的市場 北美洲

評估新藥和化學品安全性的需求不斷成長是全球體外毒理學測試市場的主要驅動力。 FDA 和 EMA 等監管機構要求進行全面的安全評估才能獲得批准。考慮到道德問題和理解的進步，體外測試提供了一種高效且經濟高效的方法來滿足這些要求。它與減少動物試驗一致，並加速藥物發現的安全性評估。

體外毒理學技術的進步

體外毒理學的技術進步有助於市場成長。細胞培養技術的創新，例如 3D 模型和晶片器官平台，提高了模擬組織複雜性的準確性。自動化、機器人技術、成像技術和微流體設備提高了測試效率、預測能力和生理相關性。

提高對安全測試重要性的認知

利害關係人對安全評估必要性的認知不斷提高是推動市場的關鍵趨勢。道德問題、消費者意識、監管指南和媒體報告促使產業和研究人員優先考慮安全評估。體外測試作為一種更具社會責任感的方法而受到重視。

主要市場挑戰

生物系統的複雜性

複製生物系統內複雜的相互作用提出了挑戰。體外模型通常無法再現系統效應和複雜的生理反應，限制了預測的準確性。

與某些端點的相關性有限

體外模型可能無法很好地捕捉一些多方面的毒理學終點。這種限制影響了傳統動物試驗的替代，並限制了在特定監管和研究背景下的應用。

長期和慢性影響

使用短期體外測定評估長期和慢性影響提出了挑戰。長期暴露和累積效應的複雜性很難在有限的時間內複製。

主要市場趨勢

個人化醫療應用

體外毒理學符合個人化醫療趨勢，根據遺傳和生理特徵評估個體對毒物的反應。這種方法有助於風險評估，為治療決策提供資訊，並識別用於即時毒性監測的生物標記。

細分市場洞察

技術洞察

反應性細胞培養技術因其準確性而在市場上佔據主導地位。在受控環境中模擬細胞反應有助於對各種化合物進行毒性測試。在進步和應用的推動下，該細分市場預計將經歷最高的年複合成長率。

應用洞察

由於監管機構要求進行全面的安全評估，系統毒理學測試引領市場。這種方法無需動物測試即可預測對多個器官系統的潛在不利影響。它有助於藥物開發和風險評估。

方法見解

細胞檢測由於直接評估對人類細胞的毒性作用而佔據主導地位。高通量能力和對細胞途徑的機制洞察提高了效率和理解。

最終使用者見解

製藥業是主要的最終用戶。監管要求、安全評估和早期風險識別推動了藥物開發中體外毒性測試的採用。

區域洞察

北美在先進的製藥工業和嚴格的監管框架的支持下引領市場。該地區的安全測試意識、道德問題和技術進步有助於成長。

目錄

第 1 章：產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 研究年份
    • 主要市場區隔

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要產業夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量與驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球體外毒理學測試市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依技術分類（細胞培養技術、高通量技術、分子影像、組學技術）
    • 按應用（全身性毒理學、皮膚毒性、內分泌干擾、眼部毒性、其他）
    • 依方法（細胞測定、生化測定、In-Silico、Ex-Vivo）
    • 按最終用戶（製藥業、化妝品和家用產品、學術機構和研究實驗室、診斷、化學工業、食品工業）
    • 按公司分類 (2022)
    • 按地區
  • 市場地圖

第 6 章：北美體外毒理學測試市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依技術
    • 按應用
    • 依方法
    • 按最終用戶
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第 7 章：歐洲體外毒理學測試市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依技術
    • 按應用
    • 依方法
    • 按最終用戶
    • 按國家/地區
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第 8 章：亞太體外毒理學測試市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依技術
    • 按應用
    • 依方法
    • 按最終用戶
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲

第 9 章：南美洲體外毒理學測試市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依技術
    • 按應用
    • 依方法
    • 按最終用戶
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲體外毒理學測試市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依技術
    • 按應用
    • 依方法
    • 按最終用戶
    • 按國家/地區
  • MEA：國家分析
    • 南非體外毒理學測試
    • 沙烏地阿拉伯體外毒理學測試
    • 阿拉伯聯合大公國體外毒理學測試

第 11 章：市場動態

  • 促進要素
  • 挑戰

第 12 章：市場趨勢與發展

  • 最近的發展
  • 產品發布
  • 併購

第 13 章：大環境分析

第 14 章：波特的五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第15章：競爭格局

  • 商業概覽
  • 公司概況
  • 產品與服務
  • 財務（上市公司）
  • 最近的發展
  • SWOT分析
    • Charles River Laboratories International, Inc.
    • SGS SA
    • Merck KGaA
    • Eurofins Scientific
    • Abbott Laboratories
    • Laboratory Corporation of America Holdings
    • Evotec SE
    • Thermo Fisher Scientific, Inc.
    • Quest Diagnostics Incorporated
    • Agilent Technolgies, Inc.
    • Catalent, Inc.

第 16 章：策略建議

簡介目錄
Product Code: 15986

The Global In-vitro Toxicology Testing Market reached a valuation of USD 16.09 Billion in 2022 and is projected to exhibit strong growth with a Compound Annual Growth Rate (CAGR) of 9.66% and expected to reach USD 27.88 Billion by 2028. In-vitro toxicology testing involves scientific processes to assess the potential toxic effects of various substances on biological systems outside living organisms. These evaluations are typically conducted in controlled laboratory settings using test tubes, culture dishes, or artificial systems, thus replicating the Latin term "in vitro," meaning "in glass." This approach provides insights into toxicological impacts at cellular, molecular, and biochemical levels, serving as a valuable tool in assessing chemical, drug, cosmetic, and consumer product safety without subjecting animals or humans to harm.

Key Market Drivers

Increasing Demand for New Drug and Chemical Safety Assessment

Market Overview
Forecast Period2024-2028
Market Size 2022USD 16.09 Billion
Market Size 2028USD 27.88 Billion
CAGR 2023-20289.66%
Fastest Growing SegmentCell Culture Technologies
Largest MarketNorth America

The escalating need for assessing the safety of new drugs and chemicals is a major driver for the Global In-vitro Toxicology Testing Market. Regulatory agencies such as the FDA and EMA demand comprehensive safety assessments for approval. In-vitro testing offers an efficient and cost-effective means to meet these requirements, considering ethical concerns and advancements in understanding. It aligns with reduced animal testing and accelerates safety evaluations in drug discovery.

Advancements in In-Vitro Toxicology Technologies

Technological progress in in-vitro toxicology is instrumental in market growth. Innovations in cell culture techniques, such as 3D models and organ-on-a-chip platforms, improve accuracy in mimicking tissue complexities. Automation, robotics, imaging technologies, and microfluidic devices enhance testing efficiency, predictive capabilities, and physiological relevance.

Increasing Awareness of Safety Testing Importance

Growing awareness among stakeholders about the necessity of safety assessments is a key trend driving the market. Ethical concerns, consumer awareness, regulatory guidelines, and media coverage prompt industries and researchers to prioritize safety evaluations. In-vitro testing gains prominence as a more socially responsible approach.

Key Market Challenges

Complexity of Biological Systems

Replicating intricate interactions within biological systems poses challenges. In-vitro models often fall short in reproducing systemic effects and complex physiological responses, limiting predictive accuracy.

Limited Relevance for Certain Endpoints

Some multifaceted toxicological endpoints may not be well-captured by in-vitro models. This limitation impacts the replacement of traditional animal testing and restricts application in specific regulatory and research contexts.

Long-Term and Chronic Effects

Assessing long-term and chronic effects using short-term in-vitro assays presents challenges. Complexities of chronic exposures and cumulative effects are difficult to replicate within limited time frames.

Key Market Trends

Personalized Medicine Applications

In-vitro toxicology aligns with personalized medicine trends, assessing individual responses to toxicants based on genetic and physiological characteristics. This approach aids risk assessments, informs treatment decisions, and identifies biomarkers for real-time toxicity monitoring.

Segmental Insights

Technology Insights

Reactive cell culture technology dominates the market due to its accuracy. Mimicking cellular responses in controlled environments facilitates toxicity testing across various compounds. This segment is projected to experience the highest CAGR, driven by advancements and applications.

Application Insights

Systemic toxicology testing leads the market as regulatory agencies demand comprehensive safety assessments. This approach predicts potential adverse effects on multiple organ systems without animal testing. It aids drug development and risk assessment.

Method Insights

Cellular assays are dominant due to their direct assessment of toxic effects on human cells. High-throughput capabilities and mechanistic insights into cellular pathways enhance efficiency and understanding.

End-User Insights

The pharmaceutical industry is a major end-user. Regulatory requirements, safety assessments, and early-stage risk identification drive in-vitro toxicity testing adoption in drug development.

Regional Insights

North America leads the market, supported by advanced pharmaceutical industries and stringent regulatory frameworks. Awareness of safety testing, ethical concerns, and technological advancements in the region contribute to growth.

Key Market Players

  • Charles River Laboratories International, Inc.
  • SGS S.A.
  • Merck KGaA
  • Eurofins Scientific
  • Abbott Laboratories
  • Laboratory Corporation of America Holdings
  • Evotec S.E.
  • Thermo Fisher Scientific, Inc.
  • Quest Diagnostics Incorporated
  • Agilent Technologies, Inc

Report Scope:

In this report, the Global In-vitro Toxicology Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below.

In-vitro Toxicology Testing Market, By Technology:

  • Cell Culture Technology
  • High Throughput Technology
  • Molecular Imaging
  • OMICS Technology

In-vitro Toxicology Testing Market, By Application:

  • Systemic Toxicology
  • Dermal Toxicity
  • Endocrine Disruption
  • Occular Toxicity
  • Others

In-vitro Toxicology Testing Market, By Method:

  • Cellular Assay
  • Biochemical Assay
  • In-silico
  • Ex-vivo

In-vitro Toxicology Testing Market, By End User:

  • Pharmaceutical Industry
  • Cosmetics & Household Products
  • Academic Institutes & Research Laboratories
  • Diagnostics
  • Chemicals Industry
  • Food Industry

Global In-vitro Toxicology Testing Market, By region:

  • North America
  • United States
  • Canada
  • Mexico
  • Asia-Pacific
  • China
  • India
  • South Korea
  • Australia
  • Japan
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global In-vitro Toxicology Testing Market.

Available Customizations:

  • Global In-vitro Toxicology Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global In-vitro Toxicology Testing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technology (Cell Culture Technology, High Throughput Technology, Molecular Imaging, OMICS Technology)
    • 5.2.2. By Application (Systemic Toxicology, Dermal Toxicity, Endocrine Disruption, Occular Toxicity, Others)
    • 5.2.3. By Method (Cellular Assay, Biochemical Assay, In-Silico, Ex-Vivo)
    • 5.2.4. By End-User (Pharmaceutical Industry, Cosmetics & Household Products, Academic Institutes & Research Laboratories, Diagnostics, Chemicals Industry, Food Industry)
    • 5.2.5. By Company (2022)
    • 5.2.6. By Region
  • 5.3. Market Map

6. North America In-vitro Toxicology Testing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technology
    • 6.2.2. By Application
    • 6.2.3. By Method
    • 6.2.4. By End-User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States In-vitro Toxicology Testing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Technology
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By Method
        • 6.3.1.2.4. By End-User
    • 6.3.2. Mexico In-vitro Toxicology Testing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Technology
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By Method
        • 6.3.2.2.4. By End-User
    • 6.3.3. Canada In-vitro Toxicology Testing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Technology
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By Method
        • 6.3.3.2.4. By End-User

7. Europe In-vitro Toxicology Testing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technology
    • 7.2.2. By Application
    • 7.2.3. By Method
    • 7.2.4. By End-User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France In-vitro Toxicology Testing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Technology
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By Method
        • 7.3.1.2.4. By End-User
    • 7.3.2. Germany In-vitro Toxicology Testing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Technology
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By Method
        • 7.3.2.2.4. By End-User
    • 7.3.3. United Kingdom In-vitro Toxicology Testing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Technology
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By Method
        • 7.3.3.2.4. By End-User
    • 7.3.4. Italy In-vitro Toxicology Testing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Technology
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By Method
        • 7.3.4.2.4. By End-User
    • 7.3.5. Spain In-vitro Toxicology Testing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Technology
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By Method
        • 7.3.5.2.4. By End-User

8. Asia-Pacific In-vitro Toxicology Testing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technology
    • 8.2.2. By Application
    • 8.2.3. By Method
    • 8.2.4. By End-User
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China In-vitro Toxicology Testing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Technology
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By Method
        • 8.3.1.2.4. By End-User
    • 8.3.2. India In-vitro Toxicology Testing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Technology
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By Method
        • 8.3.2.2.4. By End-User
    • 8.3.3. South Korea In-vitro Toxicology Testing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Technology
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By Method
        • 8.3.3.2.4. By End-User
    • 8.3.4. Japan In-vitro Toxicology Testing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Technology
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By Method
        • 8.3.4.2.4. By End-User
    • 8.3.5. Australia In-vitro Toxicology Testing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Technology
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By Method
        • 8.3.5.2.4. By End-User

9. South America In-vitro Toxicology Testing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technology
    • 9.2.2. By Application
    • 9.2.3. By Method
    • 9.2.4. By End-User
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil In-vitro Toxicology Testing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Technology
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By Method
        • 9.3.1.2.4. By End-User
    • 9.3.2. Argentina In-vitro Toxicology Testing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Technology
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By Method
        • 9.3.2.2.4. By End-User
    • 9.3.3. Colombia In-vitro Toxicology Testing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Technology
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By Method
        • 9.3.3.2.4. By End-User

10. Middle East and Africa In-vitro Toxicology Testing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technology
    • 10.2.2. By Application
    • 10.2.3. By Method
    • 10.2.4. By End-User
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa In-vitro Toxicology Testing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Technology
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By Method
        • 10.3.1.2.4. By End-User
    • 10.3.2. Saudi Arabia In-vitro Toxicology Testing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Technology
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By Method
        • 10.3.2.2.4. By End-User
    • 10.3.3. UAE In-vitro Toxicology Testing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Technology
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By Method
        • 10.3.3.2.4. By End-User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. PESTLE Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Product

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Company Snapshot
  • 15.3. Products & Services
  • 15.4. Financials (In case of listed companies)
  • 15.5. Recent Developments
  • 15.6. SWOT Analysis
    • 15.6.1. Charles River Laboratories International, Inc.
    • 15.6.2. SGS S.A.
    • 15.6.3. Merck KGaA
    • 15.6.4. Eurofins Scientific
    • 15.6.5. Abbott Laboratories
    • 15.6.6. Laboratory Corporation of America Holdings
    • 15.6.7. Evotec S.E.
    • 15.6.8. Thermo Fisher Scientific, Inc.
    • 15.6.9. Quest Diagnostics Incorporated
    • 15.6.10. Agilent Technolgies, Inc.
    • 15.6.11. Catalent, Inc.

16. Strategic Recommendations